These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1382029)
1. [Liver transplantation and hepatitis B virus. Some reasons to advance]. Samuel D Gastroenterol Clin Biol; 1992; 16(5):421-4. PubMed ID: 1382029 [No Abstract] [Full Text] [Related]
3. Long-term immunoprophylaxis for hepatitis B virus reinfection after liver transplantation. Lee WC; Jeng LB; Wang CC; Chen MF; Chien RN; Chiu CT; Ling DY; Liaw YF; Chang CH Transplant Proc; 1996 Jun; 28(3):1699-700. PubMed ID: 8658846 [No Abstract] [Full Text] [Related]
4. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatitis B. Samuel D; Bismuth H Gastroenterol Clin North Am; 1993 Jun; 22(2):271-83. PubMed ID: 8509171 [No Abstract] [Full Text] [Related]
6. Recurrence of HDV infection after liver transplantation. Bettale G; Alberti A; Belli LS; Rondinara G; De Carlis L; Vai C; Zavaglia C; Belli L; Ideo G Prog Clin Biol Res; 1993; 382():403-7. PubMed ID: 8502710 [No Abstract] [Full Text] [Related]
7. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis]. Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267 [TBL] [Abstract][Full Text] [Related]
8. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft. Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852 [No Abstract] [Full Text] [Related]
9. Further inquiry into treating hepatitis C with recombinant interferon alpha. Puoti C; Fuiano B; Annovazzi G; Pannullo A; Patane F Ital J Gastroenterol; 1992 Feb; 24(2):111. PubMed ID: 1576363 [No Abstract] [Full Text] [Related]
10. Recurrence of hepatitis B in liver transplants treated with antiviral therapy. Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis. McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840 [No Abstract] [Full Text] [Related]
12. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis. McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854 [No Abstract] [Full Text] [Related]
13. Review: hepatitis B immune globulin for prevention of hepatitis B infection. Zuckerman JN J Med Virol; 2007 Jul; 79(7):919-21. PubMed ID: 17516515 [TBL] [Abstract][Full Text] [Related]
14. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation. Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736 [No Abstract] [Full Text] [Related]
15. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections]. Lucena JF; Herrero JI An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947 [TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse. Samuel D; Feray C; Bismuth H Clin Transpl; 1994; ():157-62. PubMed ID: 7547534 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155 [TBL] [Abstract][Full Text] [Related]
18. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978 [TBL] [Abstract][Full Text] [Related]
19. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation. Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584 [TBL] [Abstract][Full Text] [Related]